On Friday Clorox Co. (NYSE:CLX) posted solid fiscal second quarter earnings results and offered a 2017 outlook that matched Wall Street’s expectations.

Written by StockNews.com

The Oakland-based cleaning and consumer products maker reported adjusted Q2 EPS of $1.25, which was $0.03 better than the Wall Street consensus estimate of $1.22. Revenues rose 4.5% from last year to $1.41 billion, matching analysts’ $1.41 billion view. Clorox also noted that sales volume grew 8% in the latest period, with all reportable segments seeing gains.

Looking ahead, CLX forecast full-year 2017 EPS to range from $5.23 to $5.35, in-line with Wall Street expectations of $5.32. Revenues are seen rising 3-4% to approximately $5.93 to $5.99 billion, also in-line with analysts’ $5.97 billion view. It’s worth noting that Clorox bumped up the low end of that revenue guidance, as it previously expected gains of 2-4% (versus 3-4% now).

The company commented via press release:

“I’m very pleased with the results we’re reporting today, the highlight being we delivered our second consecutive quarter of 8 percent volume growth. This is the highest volume increase we’ve seen in nearly 10 years, with gains in each of our segments in the U.S. and International,” said Chairman and CEO Benno Dorer. “Excluding the noncash charge, we delivered strong earnings per share growth on top of 18 percent growth in the year-ago period. Notably, we continue to drive cost savings and productivity improvements, including in International, which delivered significant margin improvement.”

...Year-to-date, CLX has gained 0.85%, versus a 1.90% rise in the benchmark S&P 500 index during the same period.

CLX currently has a StockNews.com POWR Rating of B (Buy), and is ranked #6 of 16 stocks in the Consumer Goods category.